UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Invisible Barriers to Clinical Trials: The Impact of Structural, Infrastructural, and Procedural Barriers to Opening Oncology Clinical Trials

Journal of clinical oncology, 2006-10, Vol.24 (28), p.4545-4552

2006

Volltextzugriff (PDF)

Molecular Characteristics of Bronchioloalveolar Carcinoma and Adenocarcinoma, Bronchioloalveolar Carcinoma Subtype, Predict Response to Erlotinib

Journal of clinical oncology, 2008-03, Vol.26 (9), p.1472-1478

2008

Volltextzugriff (PDF)

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5407-5415

2008

Volltextzugriff (PDF)

Phase II Clinical Trial of the Epothilone B Analog, Ixabepilone, in Patients With Non–Small-Cell Lung Cancer Whose Tumors Have Failed First-Line Platinum-Based Chemotherapy

Journal of clinical oncology, 2007-08, Vol.25 (23), p.3448-3455

2007

Volltextzugriff (PDF)

Steps and Time to Process Clinical Trials at the Cancer Therapy Evaluation Program

Journal of clinical oncology, 2009-04, Vol.27 (11), p.1761-1766

2009

Volltextzugriff (PDF)

Inhibition of angiogenesis in the treatment of non‐small cell lung cancer

Cancer science, 2007-12, Vol.98 (12), p.1825-1830

2007

Volltextzugriff (PDF)

Processes to Activate Phase III Clinical Trials in a Cooperative Oncology Group: The Case of Cancer and Leukemia Group B

Journal of clinical oncology, 2006-10, Vol.24 (28), p.4553-4557

2006

Volltextzugriff (PDF)

E-66. Clinical experience with Tarceva

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S82-S82

Sandier, Alan B.

2003

Volltextzugriff (PDF)

Targeting Angiogenesis in Lung Cancer

Seminars in oncology, 2005-12, Vol.32 (6), p.16-22

Sandler, Alan B.

2005

Volltextzugriff (PDF)

COX-2 inhibition and lung cancer: The role of COX-2 carcinogenesis

Seminars in oncology, 2004, Vol.31 (2), p.45-52

2004

Volltextzugriff (PDF)

Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2005-10, Vol.56 (4), p.329-336

2005

Volltextzugriff (PDF)

Treatment of non-small cell lung cancer, Stage IV ACCP evidence-based clinical practice guidelines (2nd Edition): Diagnosis and management of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)

Chest, 2007, Vol.132 (3)

2007

Volltextzugriff (PDF)

Redefining bronchioloalveolar carcinoma: Non-small cell lung cancer

Seminars in oncology, 2005, Vol.32 (3), p.329-335

2005

Volltextzugriff (PDF)

Role of computed tomography in the staging of primary melanoma

Journal of clinical oncology, 1993-04, Vol.11 (4), p.638-643

1993

Volltextzugriff (PDF)

Phase I trial of topotecan plus vinorelbine with/without filgrastim (G-CSF) in patients with refractory malignancies

American journal of clinical oncology, 2002-08, Vol.25 (4), p.337-339

2002

Volltextzugriff (PDF)

A Phase I Pilot Study of BCNU plus Thymidine in Patients with Refractory Cancer

Cancer investigation, 1996, Vol.14 (3), p.218-224

1996

Volltextzugriff (PDF)

Neuron-specific enolase as a tumor marker in metastatic melanoma

American journal of clinical oncology, 1994-10, Vol.17 (5), p.430-431

1994

Volltextzugriff (PDF)

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

Journal of clinical oncology, 2006-05, Vol.24 (13), p.2038-2043

2006

Volltextzugriff (PDF)

Epidermal growth factor receptor: a promising target in solid tumours

Cancer treatment reviews, 2004-02, Vol.30 (1), p.1-17

2004

Volltextzugriff (PDF)

Presence of hydrosalpinx correlated to endometrial inflammatory response in vivo

Fertility and sterility, 2006-10, Vol.86 (4), p.972-976

2006

Volltextzugriff (PDF)

Cytoplasmic Clusterin Expression Is Associated with Longer Survival in Patients with Resected Non–Small Cell Lung Cancer

Cancer epidemiology, biomarkers & prevention, 2007-09, Vol.16 (9), p.1845-1851

2007

Volltextzugriff (PDF)

Phase II Trial of Bexarotene Capsules in Patients With Advanced Non–Small-Cell Lung Cancer After Failure of Two or More Previous Therapies

Journal of clinical oncology, 2006-10, Vol.24 (30), p.4848-4854

2006

Volltextzugriff (PDF)

Activated STAT3 as a Correlate of Distant Metastasis in Prostate Cancer: A Secondary Analysis of Radiation Therapy Oncology Group 86-10

Urology (Ridgewood, N.J.), 2007-03, Vol.69 (3), p.505-509

2007

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Inhibitors in Lung Cancer Therapy

Seminars in respiratory and critical care medicine, 2004-01, Vol.25, p.17-27

2004

Volltextzugriff (PDF)

A double-blind, placebo-controlled trial of transdermal fentanyl after abdominal hysterectomy. Analgesic, respiratory, and pharmacokinetic effects

Anesthesiology (Philadelphia), 1994-11, Vol.81 (5), p.1169-1180

1994

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(22)
Medical Sciences
(22)
Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Humans
(20)
Oncology
(16)
Tumors
(14)
Female
(12)
Male
(11)
Middle Aged
(11)
Aged
(10)
Adult
(9)
Pneumology
(8)
Tumors Of The Respiratory System And Mediastinum
(8)
Lung Neoplasms - Drug Therapy
(7)
Aged, 80 And Over
(5)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(5)
Survival Analysis
(5)
Treatment Outcome
(5)
Antineoplastic Agents - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Invisible Barriers to Clinical Trials: The Impact of Structural, Infrastructural, and Procedural Barriers to Opening Oncology Clinical Trials

Molecular Characteristics of Bronchioloalveolar Carcinoma and Adenocarcinoma, Bronchioloalveolar Carcinoma Subtype, Predict Response to Erlotinib

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Phase II Clinical Trial of the Epothilone B Analog, Ixabepilone, in Patients With Non–Small-Cell Lung Cancer Whose Tumors Have Failed First-Line Platinum-Based Chemotherapy

Steps and Time to Process Clinical Trials at the Cancer Therapy Evaluation Program

Inhibition of angiogenesis in the treatment of non‐small cell lung cancer

Processes to Activate Phase III Clinical Trials in a Cooperative Oncology Group: The Case of Cancer and Leukemia Group B

E-66. Clinical experience with Tarceva

Targeting Angiogenesis in Lung Cancer

COX-2 inhibition and lung cancer: The role of COX-2 carcinogenesis

Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors

Treatment of non-small cell lung cancer, Stage IV ACCP evidence-based clinical practice guidelines (2nd Edition): Diagnosis and management of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)

Redefining bronchioloalveolar carcinoma: Non-small cell lung cancer

Role of computed tomography in the staging of primary melanoma

Phase I trial of topotecan plus vinorelbine with/without filgrastim (G-CSF) in patients with refractory malignancies

A Phase I Pilot Study of BCNU plus Thymidine in Patients with Refractory Cancer

Neuron-specific enolase as a tumor marker in metastatic melanoma

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

Epidermal growth factor receptor: a promising target in solid tumours

Presence of hydrosalpinx correlated to endometrial inflammatory response in vivo

Cytoplasmic Clusterin Expression Is Associated with Longer Survival in Patients with Resected Non–Small Cell Lung Cancer

Phase II Trial of Bexarotene Capsules in Patients With Advanced Non–Small-Cell Lung Cancer After Failure of Two or More Previous Therapies

Activated STAT3 as a Correlate of Distant Metastasis in Prostate Cancer: A Secondary Analysis of Radiation Therapy Oncology Group 86-10

Epidermal Growth Factor Receptor Inhibitors in Lung Cancer Therapy

A double-blind, placebo-controlled trial of transdermal fentanyl after abdominal hysterectomy. Analgesic, respiratory, and pharmacokinetic effects

Suchergebnisse filtern